Table 2.
Characteristics | Studies | TB patients | Combined effect (95%Cl) | P-value |
---|---|---|---|---|
Study population | ||||
Studies ≥100 patients | 11 | 150,672 | 1.9% (1.9% - 2%) | <0.001 |
Studies <100 patients | 5 | 393 | 7.9% (5.2% -10.6%) | |
Geographic region | ||||
Studies from various regions | 14 | 2051 | 4.6% (3.7% - 5.5%) | 0.016 |
National level surveys | 2 | 149,014 | 1.9% (1.8% - 2%) | |
MDR-MTB isolation | ||||
Culture only | 8 | 150,020 | 1.9% (1.9% - 2%) | 0.010 |
Mixeda | 8 | 1045 | 4.3% (3.1% - 5.5%) | |
Types of patients | ||||
New cases | 14 | 146,320 | 2% (1% - 2%) | <0.001 |
Previously treated cases | 12 | 7584 | 15% (12% - 17%) | |
All studies | 16 | 151,065 | 6% (4% - 8%) |
Keys: aCulture and molecular tests, SE standard error, CI confidence interval